title: CNS sites cooperate to detect duplicate subjects with a clinical trial subject registry.
abstract: OBJECTIVE
  To report the results of the first 1,132 subjects in a pilot project where local central nervous system trial sites collaborated in the use of a subject database to identify potential duplicate subjects.
  
  
  METHODS
  Central nervous system sites in Los Angeles and Orange County, California, were contacted by the lead author to seek participation in the project. CTSdatabase, a central nervous system-focused trial subject registry, was utilized to track potential subjects at pre-screen. Subjects signed an institutional review board-approved authorization prior to participation, and site staff entered their identifiers by accessing a website. Sites were prompted to communicate with each other or with the database administrator when a match occurred between a newly entered subject and a subject already in the database.
  
  
  RESULTS
  Between October 30, 2011, and August 31, 2012, 1,132 subjects were entered at nine central nervous system sites. Subjects continue to be entered, and more sites are anticipated to begin participation by the time of publication. Initially, there were concerns at a few sites over patient acceptance, financial implications, and/or legal and privacy issues, but these were eventually overcome. Patient acceptance was estimated to be above 95 percent. Duplicate Subjects (those that matched several key identifiers with subjects at different sites) made up 7.78 percent of the sample and Certain Duplicates (matching identifiers with a greater than 1 in 10 million likelihood of occurring by chance in the general population) accounted for 3.45 percent of pre-screens entered into the database. Many of these certain duplicates were not consented for studies because of the information provided by the registry.
  
  
  CONCLUSIONS
  The use of a clinical trial subject registry and cooperation between central nervous system trial sites can reduce the number of duplicate and professional subjects entering clinical trials. To be fully effective, a trial subject database could be integrated into protocols across pharmaceutical companies, thereby mandating site participation and increasing the likelihood that duplicate subjects will be removed before they enter (and negatively affect) clinical trials.
authors.affiliation: Dr. Shiovitz is from CTSdatabase, LLC, in Beverly Hills, California and California Neuroscience Research Medical Group, Inc., Sherman Oaks, California; Dr. Wilcox is from Pharmacology Research Institute, Los Alamitos, California; Ms. Gevorgyan is from California Neuroscience Research Medical Group, Inc., Sherman Oaks, and Mr. Shawkat is from CTSdatabase, LLC, in Beverly Hills, California.
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Shiovitz
authors.forename: Charles S
authors.initials: CS
authors.lastname: Wilcox
authors.forename: Lilit
authors.initials: L
authors.lastname: Gevorgyan
authors.forename: Adnan
authors.initials: A
authors.lastname: Shawkat
keywords: Duplicate subjects; investigator collaboration; professional patients; professional subjects; site cooperation; subject database; subject registry
references.citation: Am J Psychiatry. 2002 Mar;159(3):469-73
references.pmid: 11870014
references.citation: Perspect Biol Med. 2003 Fall;46(4):508-20
references.pmid: 14593220
references.citation: J Clin Psychiatry. 2011 Sep;72(9):1284; author reply 1284-5
references.pmid: 21951988
references.citation: Schizophr Bull. 2010 May;36(3):504-9
references.pmid: 18723840
references.citation: JAMA. 2011 Mar 23;305(12):1236-7
references.pmid: 21406636
references.citation: Am J Ther. 2008 Sep-Oct;15(5):450-7
references.pmid: 18806521
references.citation: J Clin Psychiatry. 2011 Apr;72(4):464-72
references.pmid: 21527123
references.citation: Int J Neuropsychopharmacol. 2012 Aug;15(7):1003-14
references.pmid: 22217384
references.citation: Clin Med Res. 2007 Jun;5(2):91-7
references.pmid: 17607043
references.citation: J Clin Psychiatry. 2012 Jun;73(6):856-64
references.pmid: 22687813